PTEN Expression Causes Feedback Upregulation of Insulin Receptor Substrate 2

REFERENCES

• Ali, I. U., L. M. Schriml, and M. Dean. 1999. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J. Natl. Cancer Inst. 91:1922–1932.
   PubMed Web of Science ®Google Scholar
• Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868.
   PubMed Web of Science ®Google Scholar
• Carpenter, C. L., and L. C. Cantley. 1996. Phosphoinositide 3-kinase and the regulation of cell growth. Biochim. Biophys. Acta 1288:M11–M16.
   PubMedGoogle Scholar
• Dahia, P. L., R. C. Aguiar, J. Alberta, J. B. Kum, S. Caron, H. Sill, D. J. Marsh, J. Ritz, A. Freedman, C. Stiles, and C. Eng. 1999. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum. Mol. Genet. 8:185–193.
   PubMed Web of Science ®Google Scholar
• Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905–2927.
   PubMed Web of Science ®Google Scholar
• Davies, M. A., Y. Lu, T. Sano, X. Fang, P. Tang, R. LaPushin, D. Koul, R. Bookstein, D. Stokoe, W. K. Yung, G. B. Mills, and P. A. Steck. 1998. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res. 58:5285–5290.
   PubMed Web of Science ®Google Scholar
• Di Cristofano, A., B. Pesce, C. Cordon-Cardo, and P. P. Pandolfi. 1998. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19:348–355.
   PubMed Web of Science ®Google Scholar
• Furnari, F. B., H. J. Huang, and W. K. Cavenee. 1998. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 58:5002–5008.
   PubMed Web of Science ®Google Scholar
• Gao, X., T. P. Neufeld, and D. Pan. 2000. Drosophila PTEN regulates cell growth and proliferation through P13K-dependent and -independent pathways. Dev. Biol. 221:404–418.
   PubMedGoogle Scholar
• Gil, E. B., E. Malone Link, L. X. Liu, C. D. Johnson, and J. A. Lees. 1999. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc. Natl. Acad. Sci. USA 96:2925–2930.
   PubMedGoogle Scholar
• Goberdhan, D. C., N. Paricio, E. C. Goodman, M. Mlodzik, and C. Wilson. 1999. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev. 13:3244–3258.
   PubMed Web of Science ®Google Scholar
• Harkin, D. P., J. M. Bean, D. Miklos, Y. H. Song, V. B. Truong, C. Englert, F. C. Christians, L. W. Ellisen, S. Maheswaran, J. D. Oliner, and D. A. Haber. 1999. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97:575–586.
   PubMed Web of Science ®Google Scholar
• Haruta, T., T. Uno, J. Kawahara, A. Takano, K. Egawa, P. M. Sharma, J. M. Olefsky, and M. Kobayashi. 2000. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol. 14:783–794.
   PubMed Web of Science ®Google Scholar
• Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296–299.
   PubMed Web of Science ®Google Scholar
• He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
   PubMed Web of Science ®Google Scholar
• Huang, H., C. J. Potter, W. Tao, D. M. Li, W. Brogiolo, E. Hafen, H. Sun, and T. Xu. 1999. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 126:5365–5372.
   PubMedGoogle Scholar
• Kandel, E. S., and N. Hay. 1999. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253:210–229.
   PubMed Web of Science ®Google Scholar
• Kido, Y., D. J. Burks, D. Withers, J. C. Bruning, C. R. Kahn, M. F. White, and D. Accili. 2000. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Investig. 105:199–205.
   PubMed Web of Science ®Google Scholar
• Kim, B., P. S. Leventhal, M. F. White, and E. L. Feldman. 1998. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Endocrinology 139:4881–4889.
   PubMed Web of Science ®Google Scholar
• Kops, G. J., N. D. de Ruiter, A. M. De Vries-Smits, D. R. Powell, J. L. Bos, and B. M. Burgering. 1999. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398:630–634.
   PubMed Web of Science ®Google Scholar
• Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299–303.
   PubMed Web of Science ®Google Scholar
• Levine, R. L., C. B. Cargile, M. S. Blazes, B. van Rees, R. J. Kurman, and L. H. Ellenson. 1998. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res. 58:3254–3258.
   PubMed Web of Science ®Google Scholar
• Li, D. M., and H. Sun. 1998. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. USA 95:15406–15411.
   PubMed Web of Science ®Google Scholar
• Li, J., K. DeFea, and R. A. Roth. 1999. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 274:9351–9356.
   PubMed Web of Science ®Google Scholar
• Li, J., L. Simpson, M. Takahashi, C. Miliaresis, M. P. Myers, N. Tonks, and R. Parsons. 1998. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res. 58:5667–5672.
   PubMed Web of Science ®Google Scholar
• Li, J., C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler, and R. Parsons. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947.
   PubMed Web of Science ®Google Scholar
• Liaw, D., D. J. Marsh, J. Li, P. L. Dahia, S. I. Wang, Z. Zheng, S. Bose, K. M. Call, H. C. Tsou, M. Peacocke, C. Eng, and R. Parsons. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16:64–67.
   PubMed Web of Science ®Google Scholar
• Lynch, E. D., E. A. Ostermeyer, M. K. Lee, J. F. Arena, H. Ji, J. Dann, K. Swisshelm, D. Suchard, P. M. MacLeod, S. Kvinnsland, B. T. Gjertsen, K. Heimdal, H. Lubs, P. Moller, and M. C. King. 1997. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am. J. Hum. Genet. 61:1254–1260.
   PubMed Web of Science ®Google Scholar
• Maehama, T., and J. E. Dixon. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:13375–13378.
   PubMed Web of Science ®Google Scholar
• Michael, M. D., R. N. Kulkarni, C. Postic, S. F. Previs, G. I. Shulman, M. A. Magnuson, and C. R. Kahn. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6:87–97.
   PubMed Web of Science ®Google Scholar
• Mihaylova, V. T., C. Z. Borland, L. Manjarrez, M. J. Stern, and H. Sun. 1999. The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc. Natl. Acad. Sci. USA 96:7427–7432.
   PubMedGoogle Scholar
• Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245.
   PubMed Web of Science ®Google Scholar
• Ogg, S., and G. Ruvkun. 1998. The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol. Cell 2:887–893.
   PubMed Web of Science ®Google Scholar
• Okada, T., O. Hazeki, M. Ui, and T. Katada. 1996. Synergistic activation of PtdIns 3-kinase by tyrosine-phosphorylated peptide and beta gamma-subunits of GTP-binding proteins. Biochem. J. 317:475–480.
   PubMedGoogle Scholar
• Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857–860.
   PubMed Web of Science ®Google Scholar
• Patti, M. E., X. J. Sun, J. C. Bruening, E. Araki, M. A. Lipes, M. F. White, and C. R. Kahn. 1995. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J. Biol. Chem. 270:24670–24673.
   PubMed Web of Science ®Google Scholar
• Paz, K., R. Hemi, D. LeRoith, A. Karasik, E. Elhanany, H. Kanety, and Y. Zick. 1997. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272:29911–29918.
   PubMed Web of Science ®Google Scholar
• Paz, K., Y. F. Liu, H. Shorer, R. Hemi, D. LeRoith, M. Quan, H. Kanety, R. Seger, and Y. Zick. 1999. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J. Biol. Chem. 274:28816–28822.
   PubMed Web of Science ®Google Scholar
• Podsypanina, K., L. H. Ellenson, A. Nemes, J. Gu, M. Tamura, K. M. Yamada, C. Cordon-Cardo, G. Catoretti, P. E. Fisher, and R. Parsons. 1999. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA 96:1563–1568.
   PubMed Web of Science ®Google Scholar
• Rameh, L. E., and L. C. Cantley. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:8347–8350.
   PubMed Web of Science ®Google Scholar
• Rameh, L. E., C. S. Chen, and L. C. Cantley. 1995. Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell 83:821–830.
   PubMed Web of Science ®Google Scholar
• Rao, V. R., M. N. Corradetti, J. Chen, J. Peng, J. Yuan, G. D. Prestwich, and J. S. Brugge. 1999. Expression cloning of protein targets for 3-phosphorylated phosphoinositides. J. Biol. Chem. 274:37893–37900.
   PubMedGoogle Scholar
• Razzini, G., A. Ingrosso, A. Brancaccio, S. Sciacchitano, D. L. Esposito, and M. Falasca. 2000. Different subcellular localization and phosphoinositides binding of insulin receptor substrate protein pleckstrin homology domains. Mol. Endocrinol. 14:823–836.
   PubMed Web of Science ®Google Scholar
• Risinger, J. I., A. K. Hayes, A. Berchuck, and J. C. Barrett. 1997. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 57:4736–4738.
   PubMed Web of Science ®Google Scholar
• Rodrigues, G. A., M. Falasca, Z. Zhang, S. H. Ong, and J. Schlessinger. 2000. A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol. Cell. Biol. 20:1448–1459.
   PubMedGoogle Scholar
• Rordorf-Nikolic, T., D. J. Van Horn, D. Chen, M. F. White, and J. M. Backer. 1995. Regulation of phosphatidylinositol 3′-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J. Biol. Chem. 270:3662–3666.
   PubMed Web of Science ®Google Scholar
• Rother, K. I., Y. Imai, M. Caruso, F. Beguinot, P. Formisano, and D. Accili. 1998. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J. Biol. Chem. 273:17491–17497.
   PubMed Web of Science ®Google Scholar
• Ruvkun, G., and O. Hobert. 1998. The taxonomy of developmental control in Caenorhabditis elegans. Science 282:2033–2041.
   PubMedGoogle Scholar
• Sepp-Lorenzino, L., N. Rosen, and D. E. Lebwohl. 1994. Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line. Cell Growth Differ. 5:1077–1083.
   PubMedGoogle Scholar
• Serunian, L. A., K. R. Auger, and L. C. Cantley. 1991. Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol. 198:78–87.
   PubMedGoogle Scholar
• Shimomura, I., M. Matsuda, R. E. Hammer, Y. Bashmakov, M. S. Brown, and J. L. Goldstein. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6:77–86.
   PubMed Web of Science ®Google Scholar
• Stambolic, V., A. Suzuki, J. L. de la Pompa, G. M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J. M. Penninger, D. P. Siderovski, and T. W. Mak. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39.
   PubMed Web of Science ®Google Scholar
• Steck, P. A., M. A. Pershouse, S. A. Jasser, W. K. Yung, H. Lin, A. H. Ligon, L. A. Langford, M. L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D. H. Teng, and S. V. Tavtigian. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15:356–362.
   PubMed Web of Science ®Google Scholar
• Sun, H., R. Lesche, D. M. Li, J. Liliental, H. Zhang, J. Gao, N. Gavrilova, B. Mueller, X. Liu, and H. Wu. 1999. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3, 4, 5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA 96:6199–6204.
   PubMed Web of Science ®Google Scholar
• Sun, X. J., M. Miralpeix, M. G. Myers, E. M. Glasheen, J. M. Backer, C. R. Kahn, and M. F. White. 1992. Expression and function of IRS-1 in insulin signal transmission. J. Biol. Chem. 267:22662–22672.
   PubMed Web of Science ®Google Scholar
• Tang, E. D., G. Nunez, F. G. Barr, and K. L. Guan. 1999. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274:16741–16746.
   PubMed Web of Science ®Google Scholar
• Tanti, J. F., T. Gremeaux, E. van Obberghen, and Y. Le Marchand-Brustel. 1994. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J. Biol. Chem. 269:6051–6057.
   PubMed Web of Science ®Google Scholar
• Tashiro, H., M. S. Blazes, R. Wu, K. R. Cho, S. Bose, S. I. Wang, J. Li, R. Parsons, and L. H. Ellenson. 1997. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57:3935–3940.
   PubMed Web of Science ®Google Scholar
• Vazquez, F., S. Ramaswamy, N. Nakamura, and W. R. Sellers. 2000. Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell. Biol. 20:5010–5018.
   PubMed Web of Science ®Google Scholar
• Weng, L. P., W. M. Smith, P. L. Dahia, U. Ziebold, E. Gil, J. A. Lees, and C. Eng. 1999. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res. 59:5808–5814.
   PubMedGoogle Scholar
• Withers, D. J., J. S. Gutierrez, H. Towery, D. J. Burks, J. M. Ren, S. Previs, Y. Zhang, D. Bernal, S. Pons, G. I. Shulman, S. Bonner-Weir, and M. F. White. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904.
   PubMed Web of Science ®Google Scholar
• Wu, X., K. Senechal, M. S. Neshat, Y. E. Whang, and C. L. Sawyers. 1998. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 95:15587–15591.
   PubMed Web of Science ®Google Scholar
• Yamauchi, T., K. Tobe, H. Tamemoto, K. Ueki, Y. Kaburagi, R. Yamamoto-Honda, Y. Takahashi, F. Yoshizawa, S. Aizawa, Y. Akanuma, N. Sonenberg, Y. Yazaki, and T. Kadowaki. 1996. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol. Cell. Biol. 16:3074–3084.
   PubMed Web of Science ®Google Scholar
• Yenush, L., and M. F. White. 1997. The IRS-signalling system during insulin and cytokine action. Bioessays 19:491–500.
   PubMed Web of Science ®Google Scholar